-
Mashup Score: 3
Tirzepatide, a once weekly GIP/GLP-1 receptor agonist, reduces blood glucose and body weight in people with type 2 diabetes. The cardiovascular (CV) s…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
Original Article from The New England Journal of Medicine — Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
Source: New England Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
#Dulaglutide for the Treatment of Youths with #T2D https://t.co/EDEcN8hCmZ
-
-
Mashup Score: 0Dulaglutide effective in children with type 2 diabetes - 2 year(s) ago
New research indicates dulaglutide is effective in improving glycemic control in pediatric patients with diabetes.
Source: Contemporary PediatricsCategories: Latest Headlines, PediatricsTweet-
New research indicates #dulaglutide is effective in improving glycemic control in pediatric patients with #diabetes. https://t.co/kCb1yfxket https://t.co/pK4DGoPmhv
-
-
Mashup Score: 0Weekly dulaglutide promising in youth with type 2 diabetes - 2 year(s) ago
“Considering that dulaglutide and the GLP-1 agonist class of drugs improve A1c [and] beta-cell function … dulaglutide would provide a promising new treatment option for youth with type 2 diabetes.”
Source: www.mdedge.comCategories: Latest Headlines, PediatricsTweet-
GLP1 agonist #dulaglutide, given as a weekly injection, is poised to be a new option for youth aged 10-18 years with T2D, based on the AWARD-PEDS clinical trial. https://t.co/s9p0FkkhnU #ADA2022 https://t.co/A1MKp28n1e
-
-
Mashup Score: 0Weekly dulaglutide promising in youth with type 2 diabetes - 2 year(s) ago
“Considering that dulaglutide and the GLP-1 agonist class of drugs improve A1c [and] beta-cell function … dulaglutide would provide a promising new treatment option for youth with type 2 diabetes.”
Source: www.mdedge.comCategories: Latest Headlines, PediatricsTweet-
GLP1 agonist #dulaglutide, given as a weekly injection, is poised to be a new option for youth aged 10-18 years with T2D, based on the AWARD-PEDS clinical trial. https://t.co/b7ekOb5a40 #ADA2022 https://t.co/vfrKUS6f57
-
-
Mashup Score: 0
Adults with obesity at high cardiovascular risk saw significant reductions in visceral and ectopic fat after adding daily liraglutide 3 mg to a reduced-calorie diet and lifestyle plan, findings from a randomized controlled trial show. In a single-center study, researchers also found that the relative effects of liraglutide 3 mg (Saxenda, Novo Nordisk) on fat reduction were two times greater in
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
ICYMI: “#Liraglutide and its related products, #semaglutide and #dulaglutide, can be key components to a comprehensive risk reduction strategy for overweight and #obesity." @TheLancetEndo @UHhospitals @PBRCNews @CardiologyToday https://t.co/OVUIiQ9bCo
-
-
Mashup Score: 2
Long-term use of dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Long-term use of #dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 #diabetes. Read more @ https://t.co/lXZl7Rv7Ja #T2D #T2Diabetes #erectiledysfunction
-
-
Mashup Score: 1Dulaglutide for erectile dysfunction in type 2 diabetes - 3 year(s) ago
Erectile dysfunction is a common complication in men with type 2 diabetes, and the prevalence increases with advancing age, obesity (BMI ≥30 kg/m2), diabetes duration, poor glycaemic control, presence of diabetic late microvascular and macrovascular complications.1 Erectile dysfunction arises 10–15 years earlier in men with diabetes than in men without diabetes and is often more severe and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment by Sten Madsbad: #Dulaglutide for erectile dysfunction in type 2 #diabetes https://t.co/FuNhhWgXLR #T2D #T2Diabetes #erectiledysfunction
-
-
Mashup Score: 5
Long-term use of dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Erectile function in men with type 2 #diabetes treated with #dulaglutide: an exploratory analysis of the #REWIND placebo-controlled randomised trial https://t.co/lXZl7Rv7Ja #T2D #erectiledysfunction
-
-
Mashup Score: 3Dulaglutide for erectile dysfunction in type 2 diabetes - 3 year(s) ago
Erectile dysfunction is a common complication in men with type 2 diabetes, and the prevalence increases with advancing age, obesity (BMI ≥30 kg/m2), diabetes duration, poor glycaemic control, presence of diabetic late microvascular and macrovascular complications.1 Erectile dysfunction arises 10–15 years earlier in men with diabetes than in men without diabetes and is often more severe and…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: #Dulaglutide for erectile dysfunction in type 2 #diabetes https://t.co/FuNhhWgXLR #T2D #erectiledysfunction
-
RT @DanielJDrucker: SURPASS CVOT Design and Baseline characteristics #diabetes #CVD #T2D #Tirzepatide #Dulaglutide https://t.co/q1KUVLSjlb